CompletedNCT03478839
Study of People With Generalized Arterial Calcification of Infancy (GACI) or Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2)
Studying Generalized arterial calcification of infancy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Human Genome Research Institute (NHGRI)
- Principal Investigator
- Carlos R Ferreira Lopez, M.D.National Human Genome Research Institute (NHGRI)
- Enrollment
- 48 enrolled
- Eligibility
- 1-110 years · All sexes
- Timeline
- 2018 – 2020
Study locations (1)
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03478839 on ClinicalTrials.gov